AnPac Bio Medical Science : Reports Nine Months Ended September 30, 2021, Same Period Achieved Record Revenue Increased by 55.3%, While Non-GAAP Net Loss Reduced by 6.8% - Form 6-K
AnPac Bio-Medical Science Co., Ltd. , a biotechnology company with operations in China and the United States, announced today its unaudited financial results for the nine months ended September 30,... | November 26, 2021